Jeff Yass’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Jeff Yass’s Portfolio LSBPW Stock Details LSBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,591	Closed	-$341	–	13556
2023 Q4	$341	Buy	+12,591	New	+$417	﹤0.01%	12223

Other funds holding LSBPW

Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Valliance Asset Management Central, Hong Kong $864M AUM 906.77% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return

Q Global Advisors Fort Worth, Texas $157M AUM 29.28% 1-Year Est. Return

Jeff Yass's LSBPW Position: Q1 2024 in Review

Jeff Yass sold out of LakeShore Biopharma Warrants (LSBPW) in Q1 2024, closing a stake of 12,591 shares — an estimated $341 sold.

Jeff Yass first reported a position in LSBPW in Q4 2023 and held it in 1 quarter. The position peaked at $341 in Q4 2023. 25 funds tracked by Wall St. Rank hold LSBPW as of Q1 2024.

Jeff Yass reported no remaining LakeShore Biopharma Warrants position as of Q1 2024 after selling out during the quarter.
Jeff Yass sold 12,591 LakeShore Biopharma Warrants shares in Q1 2024, an estimated $341.
Jeff Yass first reported a position in LakeShore Biopharma Warrants in Q4 2023 and held it in 1 quarter.
Jeff Yass's LakeShore Biopharma Warrants position peaked at $341 in Q4 2023.
25 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.